It had been demonstrated that cadherin instability leads to glioma cell migration [3] and NCAMs modify the ECM by downregulating the expression of matrix metalloproteinases that degrade cadherins and, thereby, hinder tumor cell motility [4]. The gene discussed is CDH17; the disease is central nervous system cancer.